Cullinan Therapeutics, Inc. (CGEM)
10.28
+0.09
(+0.88%)
USD |
NASDAQ |
Nov 13, 16:00
10.26
-0.02
(-0.19%)
After-Hours: 19:59
Cullinan Therapeutics Market Cap : 668.84M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 668.84M |
| November 12, 2026 | 662.98M |
| November 11, 2026 | 738.45M |
| November 10, 2026 | 730.65M |
| November 09, 2026 | 763.18M |
| November 06, 2026 | 735.85M |
| November 05, 2026 | 702.67M |
| November 04, 2026 | 806.23M |
| November 03, 2026 | 1.017B |
| November 02, 2026 | 963.73M |
| October 30, 2026 | 970.19M |
| October 29, 2026 | 997.30M |
| October 28, 2026 | 1.004B |
| October 27, 2026 | 957.92M |
| October 26, 2026 | 938.56M |
| October 23, 2026 | 927.58M |
| October 22, 2026 | 963.09M |
| October 21, 2026 | 961.15M |
| October 20, 2026 | 957.28M |
| October 19, 2026 | 902.41M |
| October 16, 2026 | 834.63M |
| October 15, 2026 | 903.70M |
| October 14, 2026 | 880.46M |
| October 13, 2026 | 910.16M |
| October 12, 2026 | 965.02M |
| Date | Value |
|---|---|
| October 09, 2026 | 1.002B |
| October 08, 2026 | 997.94M |
| October 07, 2026 | 1.009B |
| October 06, 2026 | 1.049B |
| October 05, 2026 | 1.035B |
| October 02, 2026 | 1.001B |
| October 01, 2026 | 937.91M |
| September 30, 2026 | 990.84M |
| September 29, 2026 | 983.10M |
| September 28, 2026 | 965.02M |
| September 25, 2026 | 955.99M |
| September 24, 2026 | 996.65M |
| September 23, 2026 | 1.089B |
| September 22, 2026 | 1.399B |
| September 21, 2026 | 1.378B |
| September 18, 2026 | 1.361B |
| September 17, 2026 | 1.379B |
| September 16, 2026 | 1.332B |
| September 15, 2026 | 1.326B |
| September 14, 2026 | 1.317B |
| September 11, 2026 | 1.329B |
| September 10, 2026 | 1.356B |
| September 09, 2026 | 1.376B |
| September 08, 2026 | 1.400B |
| September 04, 2026 | 1.426B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Climb Bio, Inc. | 598.06M |
| Oncolytics Biotech, Inc. | 46.12M |
| Sangamo Therapeutics, Inc. | 48.47M |
| Sarepta Therapeutics, Inc. | 1.723B |
| Anixa Biosciences, Inc. | 90.61M |
Market Cap Related Metrics
| Price to Book Value | 2.378 |
| Price | 10.28 |
| Earnings Yield | -32.12% |